5-HT_1B receptor-AC-PKA signal pathway in the lateral habenula is involved in the regulation of depressive-like behaviors in 6-hydroxydopamine-induced Parkinson’s rats

References

• Löhle M, Storch A, Reichmann H. Beyond tremor and rigidity: non-motor features of Parkinson’s disease. J Neural Transm. 2009;116(11):1483–1492.
   PubMed Web of Science ®Google Scholar
• Kiss J, Csaki A, Bokor H, et al. Possible glutamatergic/aspartatergic projections to the supramammillary nucleus and their origins in the rat studied by selective [(3)H]D-aspartate labelling and immunocytochemistry. Neuroscience. 2002;111(3):671–691.
   PubMed Web of Science ®Google Scholar
• Herkenham M, Nauta WJ. Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-passage problem. J Comp Neurol. 1977;173(1):123–146.
   PubMed Web of Science ®Google Scholar
• Hikosaka O, Sesack SR, Lecourtier L, et al. Habenula: crossroad between the basal ganglia and the limbic system. J Neurosci. 2008;28(46):11825–11829.
   PubMed Web of Science ®Google Scholar
• Hong S, Hikosaka O. The globus pallidus sends reward-related signals to the lateral habenula. Neuron. 2008;60(4):720–729.
   PubMed Web of Science ®Google Scholar
• Sartorius A, Henn FA. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypotheses. 2007;69(6):1305–1308.
   PubMed Web of Science ®Google Scholar
• Lecca S, Meye FJ, Mameli M. The lateral habenula in addiction and depression: an anatomical, synaptic and behavioral overview. Eur J Neurosci. 2014;39(7):1170–1178.
   PubMed Web of Science ®Google Scholar
• Morris JS, Smith KA, Cowen PJ, et al. Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage. 1999;10(2):163–172.
   PubMed Web of Science ®Google Scholar
• Shumake J, Edwards E, Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res. 2003;963(1–2):274–281.
   PubMed Web of Science ®Google Scholar
• Yang LM, Hu B, Xia YH, et al. Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus. Behav Brain Res. 2008;188(1):84–90.
   PubMed Web of Science ®Google Scholar
• Meng H, Wang Y, Huang M, et al. Chronic deep brain stimulation of the lateral habenula nucleus in a rat model of depression. Brain Res. 2011;1422:32–38.
   PubMed Web of Science ®Google Scholar
• Li B, Piriz J, Mirrione M, et al. Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature. 2011;470(7335):535–539.
   PubMed Web of Science ®Google Scholar
• Winter C, Vollmayr B, Djodari-Irani A, et al. Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression. Behav Brain Res. 2011;216(1):463–465.
   PubMed Web of Science ®Google Scholar
• Winter C, von Rumohr A, Mundt A, et al. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behav Brain Res. 2007;184(2):133–141.
   PubMed Web of Science ®Google Scholar
• Santiago RM, Barbiero J, Gradowski RW, et al. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behav Brain Res. 2014;259:70–77.
   PubMed Web of Science ®Google Scholar
• Sourani D, Eitan R, Gordon N, et al. The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson’s disease. Eur J Neurosci. 2012;36(6):2822–2829.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang L, Zhang QJ, et al. Involvement of lateral habenula α1 subunit-containing GABAA receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson’s disease. Neuropharmacology. 2017;116:399–411.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv SX, Tang GY, et al. Activation of calcium-impermeable GluR2-containing AMPA receptors in the lateral habenula produces antidepressant-like effects in a rodent model of Parkinson’s disease. Exp Neurol. 2019;322:113058.
   PubMed Web of Science ®Google Scholar
• Tierney PL, Dégenètais E, Thierry AM, et al. Influence of the hippocampus on interneurons of the rat prefrontal cortex. Eur J Neurosci. 2004;20(2):514–524.
   PubMed Web of Science ®Google Scholar
• Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38(8):1083–1152.
   PubMed Web of Science ®Google Scholar
• De Deurwaerdère P, Di Giovanni G. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications. Prog Neurobiol. 2017;151:175–236.
   PubMed Web of Science ®Google Scholar
• Bruinvels AT, Palacios JM, Hoyer DA, et al. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn-Schmiedebergs Arch Pharmacol. 1993;347(6):569–582.
   PubMed Web of Science ®Google Scholar
• Nautiyal KM, Tritschler L, Ahmari SE, et al. A lack of serotonin1B autoreceptors results in decreased anxiety and depression-related behaviors. Neuropsychopharmacology. 2016;41(12):2941–2950.
   PubMed Web of Science ®Google Scholar
• Bechtholt AJ, Smith K, Gaughan S, et al. Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice. Physiol Behav. 2008;93(4–5):659–665.
   PubMed Web of Science ®Google Scholar
• Jones MD, Lucki I. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology. 2005;30(6):1039–1047.
   PubMed Web of Science ®Google Scholar
• Maroteaux L, Saudou F, Amlaiky N, et al. Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers. Proc Natl Acad Sci. 1992;89(7):3020–3024.
   PubMed Web of Science ®Google Scholar
• Ng GY, George SR, Zastawny RL, et al. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry. 1993;32(43):11727–11733.
   PubMed Web of Science ®Google Scholar
• Mathur BN, Capik NA, Alvarez VA, et al. Serotonin induces long-term depression at corticostriatal synapses. J Neurosci. 2011;31(20):7402–7411.
   PubMed Web of Science ®Google Scholar
• Hwang EK, Chung JM. 5HT1B receptor-mediated pre-synaptic depression of excitatory inputs to the rat lateral habenula. Neuropharmacology. 2014;81:153–165.
   PubMed Web of Science ®Google Scholar
• Lu CW, Lin TY, Huang SK, et al. 5-HT1B receptor agonist CGS12066 presynaptically inhibits glutamate release in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:122–130.
   PubMed Web of Science ®Google Scholar
• Tadaiesky MT, Dombrowski PA, Figueiredo CP, et al. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson’s disease. Neuroscience. 2008;156(4):830–840.
   PubMed Web of Science ®Google Scholar
• Sclafani A, Ackroff K. Reinforcement value of sucrose measured by progressive ratio operant licking in the rat. Physiol Behav. 2003;79(4–5):663–670.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47(4):379–391.
   PubMed Web of Science ®Google Scholar
• Fedrowitz M, Lindemann S, Löscher W, et al. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant. Neuroscience. 2003;118(3):867–878.
   PubMed Web of Science ®Google Scholar
• Tchenio A, Valentinova K, Mameli M. Can the lateral Habenula crack the serotonin code. Front Neurosci. 2016;8:34.
   Google Scholar
• Liu JH, Wu ZF, Sun J, et al. Role of AC-cAMP-PKA cascade in antidepressant action of electroacupuncture treatment in rats. Evid Based Complement Alternat Med. 2012;2012:932414.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Terwilliger RZ, Duman RS. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem. 1989;53(5):1644–1647.
   PubMed Web of Science ®Google Scholar
• Perez J, Tinelli D, Brunello N. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol. 1989;172(3):305–316.
   PubMed Web of Science ®Google Scholar
• Ozawa H, Rasenick MM. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem. 1991;56(1):330–338.
   PubMed Web of Science ®Google Scholar
• Lyu S, Guo Y, Zhang L, et al. Blockade of GABA transporter-1 and GABA transporter-3 in the lateral habenula improves depressive-like behaviors in a rat model of Parkinson’s disease. Neuropharmacology. 2020;181:108369.
   PubMed Web of Science ®Google Scholar
• Lyu S, Guo Y, Zhang L, et al. Downregulation of astroglial glutamate transporter GLT-1 in the lateral habenula is associated with depressive-like behaviors in a rat model of Parkinson’s disease. Neuropharmacology. 2021;196:108691.
   PubMed Web of Science ®Google Scholar
• Qian H, Kang X, Hu J, et al. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature. 2020;582(7813):550–556.
   PubMed Web of Science ®Google Scholar
• Wevers NR, Kasi DG, Gray T, et al. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport. Fluids Barriers CNS. 2018;15(1):23.
   PubMed Web of Science ®Google Scholar
• Salman MM, Marsh G, Kusters I, et al. Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging. Front Bioeng Biotechnol. 2020;8:573775.
   PubMed Web of Science ®Google Scholar
• Aldewachi H, Al-Zidan RN, Conner MT, et al. High-Throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases. Bioengineering (Basel). 2021;8(2):30.
   PubMed Web of Science ®Google Scholar
• Salman MM, Al-Obaidi Z, Kitchen P, et al. Advances in applying computer-aided drug design for neurodegenerative diseases. Int J Mol Sci. 2021;22(9):4688.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590.
   PubMed Web of Science ®Google Scholar